FLUBLOK® QUADRIVALENT

PROVEN FLU PROTECTION FOR PEOPLE 50+

PROVEN FLU PROTECTION FOR PEOPLE 50+

As you get older, a flu vaccine with proven protection can go a long way. FLUBLOK® QUADRIVALENT INFLUENZA VACCINE is proven to be 30% more effective than a standard-dose influenza vaccine in preventing flu in people 50+.*

*Significant results from a head-to-head clinical trial with approximately 4,300 people in each group:
FLUBLOK® QUADRIVALENT: 96 people got the flu (2.2%).
Fluarix Quadrivalent (Influenza Vaccine): 138 people got the flu (3.2%).

FLUBLOK® QUADRIVALENT is a vaccine indicated for immunization against influenza disease caused by influenza A and B strains contained in the vaccine. FLUBLOK® QUADRIVALENT is given to people 18 years of age and older.

All brand names and trademarks are property of their respective owners.

Proven
flu protection
for adults

compared to
a standard-dose
influenza vaccine

African American women in her 50s walking in a wheat field with her tight arm extended out to her side. African American women in her 50s walking in a wheat field with her tight arm extended out to her side.

A DIFFERENT KIND OF FLU SHOT

Unlike traditional flu vaccines, FLUBLOK® QUADRIVALENT is produced without the adaptation or growth of the influenza virus, and is designed to be an exact match to the seasonal flu strains anticipated by the U.S. Food and Drug Administration and the World Health Organization.

Location pin icon Location pin icon

FIND ONE NEAR YOU

Exclamation point inside a circle icon Exclamation point inside a circle icon

GET
FLU SEASON TIPS AND ALERTS

COVERAGE UNDER MAJOR HEALTH PLANS

FLUBLOK® QUADRIVALENT may be covered with no co-payment or deductible under private insurance plans.

FLUZONE® QUADRIVALENT INFLUENZA VACCINE

Helps protect people as young as 6 months of age against 4 different strains of the flu contained in the vaccine.

FLUZONE® HIGH-DOSE QUADRIVALENT INFLUENZA
VACCINE

Superior flu protection for people age 65 years and older—versus Fluzone (Influenza Vaccine).

With 4-strain protection, FLUZONE® HIGH-DOSE QUADRIVALENT builds on the legacy of the trivalent formulation, which was clinically proven to be 24.2% more effective at preventing flu than standard-dose Fluzone (Influenza Vaccine) in adults 65+.

What are Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose Quadrivalent?

Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent are vaccines indicated for immunization against disease caused by influenza A and B strains contained in the vaccine. Fluzone Quadrivalent is given to people 6 months of age and older. Flublok Quadrivalent is given to people 18 years of age and older. Fluzone High-Dose Quadrivalent is given to people 65 years of age and older.

IMPORTANT SAFETY INFORMATION

Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent should not be given to anyone who has had a severe allergic reaction to any component of the vaccine (including eggs or egg products for Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent) or after previous dose of the vaccine. In addition, Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent should not be given to anyone who has had a severe allergic reaction after previous dose of any influenza vaccine.

Tell your health care provider if you have ever had Guillain-Barré syndrome (severe muscle weakness) after a previous influenza vaccination.

If Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent are given to people with a compromised immune system, including those receiving therapies that suppress the immune system, the immune response may be lower than expected.

Vaccination with Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent may not protect all people who receive the vaccine.

For Fluzone Quadrivalent, in children 6 months through 35 months of age, the most common side effects were pain, tenderness, redness, and/or swelling where you got the shot; irritability, abnormal crying, general discomfort, drowsiness, loss of appetite, muscle aches, vomiting, and fever. In children 3 years through 8 years of age, the most common side effects were pain, redness, and/or swelling where you got the shot; muscle aches, general discomfort, and headache. In adults 18 years and older, the most common side effects were pain where you got the shot; muscle aches, headache, and general discomfort.

For Flublok Quadrivalent, in adults 18 through 49 years of age, the most common side effects were tenderness, and/or pain where you got the shot; headache, tiredness, muscle aches, and joint pain. In adults 50 years of age and older the most common side effects were tenderness, and/or pain where you got the shot; headache and tiredness.

For Fluzone High-Dose Quadrivalent, in adults 65 years of age and older, the most common side effects were pain, redness, and/or swelling where you got the shot; muscle aches, headache, and general discomfort.

For Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent, other side effects may occur.

BACK TO TOP

© 2020 Sanofi Pasteur Inc. All rights reserved.

Legal Disclaimer | Privacy Policy | Contact SANOFI | Site Map

This site is intended for use by U.S. residents only.

MAT-US-2007823 Last Updated: 09/2020